Management of Diabetes in Post-Stroke Patients

Glycemic Targets

The American Heart Association recommends individualized glycemic targets with HbA1c goals of 7-8% for most elderly patients or those with established vascular disease, along with glucose-lowering medications that have proven cardiovascular benefits to reduce recurrent stroke risk 1, 2
For patients <65 years without significant comorbidities, the target HbA1c should be ≤7% 2
For elderly patients or those with established vascular disease, the target HbA1c should be 7-8% or even 8-9% to reduce hypoglycemia risk 1, 3
During acute post-stroke care, blood glucose should be maintained between 140-180 mg/dL for critically ill patients 4, 5
Insulin therapy should be initiated for persistent hyperglycemia starting at a threshold of 180 mg/dL 5, 6

Glucose-lowering agents with proven cardiovascular benefit should be chosen to reduce future major adverse cardiovascular events 2
GLP-1 receptor agonists may be beneficial for secondary prevention, though more research is needed 1
Pioglitazone may be considered in patients ≤6 months after TIA or ischemic stroke with insulin resistance, HbA1c <7.0%, and without heart failure or bladder cancer 2

The American Diabetes Association recommends screening for diabetes/prediabetes in all stroke patients using HbA1c, which is more convenient and less affected by stress of acute illness 2, 3
Multidimensional care should include medical nutritional therapy 3, 7, regular physical activity 3, 7, weight management for overweight/obese patients 1, 8, smoking cessation 3, 7, and diabetes self-management education and support 3, 7

Blood pressure should be controlled with a target <130/80 mmHg, preferably using ACE inhibitors 9
Statins should be prescribed regardless of baseline cholesterol levels to reduce stroke risk 9

Blood glucose levels should be monitored regularly to evaluate response to therapy 4, 6
Changes in trajectory of glucose levels, nutritional status, illness/infection, renal function, and neurological function should be assessed 5, 6
BMI should be calculated at the time of stroke event and annually thereafter 8

Both hyperglycemia and hypoglycemia should be avoided as they can be detrimental to brain recovery 4, 9
Overly aggressive glucose control in elderly patients or those with established vascular disease may lead to dangerous hypoglycemia 1, 3
Failure to screen for previously undiagnosed diabetes, which affects approximately 20% of acute stroke patients, should be avoided 3, 5